3,6-Nonadien-1-ol, acetate, (3E,6Z)-
| Common Name: |
3,6-Nonadien-1-ol, acetate, (3E,6Z)- |
| IUPAC Name: |
[(3E,6Z)-nona-3,6-dienyl] acetate |
| Molecular Formula: |
C11H18O2 |
| SMILES: |
CCC=CCC=CCCOC(=O)C |
| Inchi: |
1S/C11H18O2/c1-3-4-5-6-7-8-9-10-13-11(2)12/h4-5,7-8H,3,6,9-10H2,1-2H3/b5-4-,8-7+ |
| Inchi Key: |
CMNKZQXSZSHGNF-KXKKYDSASA-N |
| Cas No: |
211323-05-6 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
182.26 |
| Mass (g/mol) |
182.131 |
| Molar Refractivity |
55.33 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
7 |
| Rings |
|
| TPSA |
26.30 |
| Hetero Atoms |
2 |
| Heavy Atoms |
13 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
75.00 @ 15.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
0.026 |
| Vapor Density (Air =1) |
>! |
| Fraction Csp3 |
0.55 |
| LogP |
2.852 |
| iLOGP |
3.18 |
| XLOGP3 |
2.82 |
| WLOGP |
2.85 |
| MLOGP |
2.67 |
| ESOL Log S |
-2.28 |
| ESOL Solubility (mg/ml) |
0.946 |
| ESOL Solubility (mol/l) |
0.005 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-3.03 |
| Ali Solubility (mg/ml) |
0.17 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.14 |
| Silicos-IT Solubility (mg/ml) |
1.31 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.41 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.773 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
1 |
| Acute Oral Toxicity |
1.645 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
